BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1200
-0.0100 (-7.69%)
May 18, 2026, 3:54 PM EST
BioLargo Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -12.91 | -11.78 | -2.4 | -3.5 | -4.47 | -7.08 |
Depreciation & Amortization | 0.43 | 0.41 | 0.26 | 0.27 | 0.05 | 0.02 |
Other Amortization | 0.23 | 0.2 | - | 0 | 0.02 | 0.12 |
Asset Writedown & Restructuring Costs | - | - | - | 0.39 | 0.2 | 0.34 |
Loss (Gain) From Sale of Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
Stock-Based Compensation | 3.65 | 3.61 | 2.48 | 2.51 | 2.36 | 2.24 |
Provision & Write-off of Bad Debts | 3.85 | 3.89 | 0.01 | 0.09 | - | - |
Other Operating Activities | -4.01 | -3.63 | -2.02 | -1.22 | -0.68 | 0.16 |
Change in Accounts Receivable | -0.85 | -1.81 | -0.57 | -1.63 | -0.55 | -0.03 |
Change in Inventory | 0.08 | 0.02 | -0.18 | -0.09 | -0.04 | 0.04 |
Change in Accounts Payable | -0.04 | 0.64 | -0.4 | 0.47 | 0.39 | 0.18 |
Change in Unearned Revenue | 0.32 | 0.28 | -0.3 | 0.29 | -0.07 | 0.04 |
Change in Other Net Operating Assets | -0.14 | -0.13 | -0.09 | 0.05 | 0.02 | 0.02 |
Operating Cash Flow | -9.38 | -8.3 | -3.21 | -2.37 | -2.76 | -3.94 |
Capital Expenditures | -0.08 | -0.05 | -1.24 | -0.48 | -0.27 | -0.02 |
Sale (Purchase) of Intangibles | - | - | - | - | - | -0.01 |
Other Investing Activities | 0.48 | 0.48 | -0.08 | - | - | - |
Investing Cash Flow | 0.4 | 0.44 | -1.32 | -0.48 | -0.27 | -0.03 |
Long-Term Debt Issued | - | 1.29 | 0.86 | 0.07 | 0.1 | - |
Total Debt Issued | 3.09 | 1.29 | 0.86 | 0.07 | 0.1 | - |
Short-Term Debt Repaid | - | - | - | - | - | -0.83 |
Long-Term Debt Repaid | - | - | -0.01 | -0.03 | -0.03 | -0.04 |
Total Debt Repaid | -0 | - | -0.01 | -0.03 | -0.03 | -0.87 |
Net Debt Issued (Repaid) | 3.09 | 1.29 | 0.85 | 0.04 | 0.07 | -0.87 |
Issuance of Common Stock | 5.31 | 4.79 | 3.59 | 3.01 | 3.66 | 5.05 |
Other Financing Activities | - | - | - | 1.61 | 0.23 | 0.05 |
Financing Cash Flow | 10.55 | 8.22 | 4.44 | 4.66 | 3.96 | 4.23 |
Foreign Exchange Rate Adjustments | -0.01 | -0.02 | 0.09 | -0.13 | -0.03 | -0.01 |
Net Cash Flow | 1.56 | 0.34 | 0.01 | 1.69 | 0.89 | 0.25 |
Free Cash Flow | -9.46 | -8.34 | -4.44 | -2.84 | -3.03 | -3.96 |
Free Cash Flow Margin | -168.63% | -107.44% | -24.98% | -23.25% | -51.55% | -156.38% |
Free Cash Flow Per Share | -0.03 | -0.03 | -0.01 | -0.01 | -0.01 | -0.02 |
Cash Interest Paid | 0.34 | 0.34 | 0.03 | 0.06 | 0.04 | 0.1 |
Cash Income Tax Paid | - | - | - | - | 0 | 0 |
Levered Free Cash Flow | -2.22 | -1.68 | -2.4 | -0.96 | -1.13 | -2 |
Unlevered Free Cash Flow | -2.05 | -1.54 | -2.36 | -0.91 | -1.11 | -1.98 |
Change in Working Capital | -0.63 | -1 | -1.54 | -0.92 | -0.25 | 0.25 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.